Transforming challenges into strategic solutions.
Expert Toxicology & PK Drug Development Consulting Services
Transforming challenges into strategic solutions.
Transforming challenges into strategic solutions.
Transforming challenges into strategic solutions.
At Bioepisteme, our mission is to empower organizations by providing expert drug development consulting services from early safety de-risking, to First-In-Human dosing, and post-marketing pharmacokinetic optimization. With more than 50+ years of combined experience in the development and optimization of biologics - we know no two programs are alike. We aim to enhance operational efficiency and drive strategic growth through tailored solutions to your nonclinical and clinical programs.

At Bioepisteme, our vision is to offer niche consulting for biotechnology space. We aim to achieve this by constantly innovating and providing exceptional services that exceed our clients' expectations.

Bioepisteme is a partnership of skilled consultants with extensive experience in the development of novel biologics - specifically we specialize in Nonclinical Regulatory Pharmacology/Toxicology and Clinical Pharmacokinetics. We are committed to delivering quality services to our clients and helping them achieve their business goals.

We take a data-driven approach to consulting, where we use advanced analytics and technology to provide insights that drive business decisions. Our approach is highly customizable to meet the unique needs of each client.
Bioepisteme can help your team de-risk your early stage drug development pipeline with customized strategies to ensure safety signals are identified early. We work with your scientists to develop and optimize your candidate selection.
At Bioepisteme we understand that advancing your candidate through the IND enabling studies is a key development milestone. We can help your teams build a strategy, help you design key studies, where needed facilitate study oversight, and support dossier preparation.
Our experience in drug development spans the entire pipeline. We think beyond just initial clinical entry and ensure there is line of sight through to commercialization for your complete nonclinical package. This avoids costly errors, lost time, and unnecessary spend.
Having a robust biomarker with pharmacokinetic metrics can substantially improve efficacy outcomes and durable healing for many patients. We leverage data-driven advanced analytics to develop precision-based approaches to support therapy decisions for physicians and patients.
At Bioepisteme we have 25+ years of experience operating and overseeing complex diagnostic CLIA laboratory testing. We understand the highly specialized technical needs overseeing the compliance but importantly it is the science that drives successful biomarker identification.
We provide fractional support and help you hire the right team. We don't pretend to do everything and know that unique challenges demands the right people. We believe that making sure you have the expertise that you need is more important than billing hours.
We can also help clients with independent opinions on assets and identify potential risks for development.
We love our customers, so feel free to visit during normal business hours.
Open today | 09:00 am – 05:00 pm |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.